Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia

Journal of Lipid Research

Volumn 43, Issue 11, 2002, Pages 1899-1907

  Attie, Alan D ^a   Krauss, Ronald M ^b,e   Gray Keller, Mark P ^a,c   Brownlie, Alison ^c   Miyazaki, Makoto ^a   Kastelein, John J ^d   Lusis, Aldons J ^b,e   Stalenhoef, Anton F H ^f   Stoehr, Jonathan P ^a   Hayden, Michael R ^c,g   Ntambi, James M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Xenon Genetics Inc   (Canada)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hyperlipidemia; Metabolic syndrome; Monounsaturated fatty acids

Indexed keywords

ACYL COENZYME A DESATURASE; CHOLESTEROL ESTER; ESTER; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DISRUPTION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CAUCASIAN; DISEASE MODEL; ENZYMOLOGY; GENE DOSAGE; GENETICS; METABOLISM; MOUSE MUTANT; NONPARAMETRIC TEST;

ANIMALS; DIETARY CARBOHYDRATES; DISEASE MODELS, ANIMAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DOSAGE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, VLDL; MICE; MICE, KNOCKOUT; STATISTICS, NONPARAMETRIC; STEAROYL-COA DESATURASE; TRIGLYCERIDES;

EID: 0036846245     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200189-JLR200     Document Type: Article

References (44)

1. Hellerstein, M. K. 1999. De novo lipogenesis in humans: Metabolic and regulatory aspects. Eur. J. Clin. Nutr. 53(Suppl 1): S53-65.
2. Zhang, L., L. Ge, S. Parimoo, K. Stenn, and S. M. Prouty. 1999. Human stearoyl-CoA desaturase: Alternative transcripts generated from a single gene by usage of tandem polyadenylation sites. Biochem. J. 340: 255-264.
3. Enoch, H. G., A. Catala, and P. Strittmatter. 1976. Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J. Biol. Chem. 251: 5095-5103.
4. Ntambi, J. M. 1999. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40: 1549-1558.
5. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
6. Tabor, D. E., J. B. Kim, B. M. Spiegelman, and P. A. Edwards. 1998. Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1. J. Biol. Chem. 273: 22052-22058.
7. Tabor, D. E., J. B. Kim, B. M. Spiegelman, and P. A. Edwards. 1999. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J. Biol. Chem. 274: 20603-20610.
8. Shimomura, I., H. Shimano, B. S. Korn, Y. Bashmakov, and J. D. Horton. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273: 35299-35306.
9. Shimomura, I., Y. Bashmakov, S. Ikemoto, J. D. Horton, M. S. Brown, and J. L. Goldstein. 1999. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA. 96: 13656-13661.
10. Miyazaki, M., Y. C. Kim, M. P. Gray-Keller, A. D. Attie, and J. M. Ntambi. 2000. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem. 275: 30132-30138.
11. Miyazaki, M., Y. C. Kim, and J. M. Ntambi. 2001. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J. Lipid Res. 42: 1018-1024.
12. Goldstein, J. L., H. G. Schrott, W. R. Hazzard, E. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52: 1544-1568.
13. Pajukanta, P., J. D. Terwilliger, M. Perola, T. Hiekkalinna, I. Nuotio, P. Ellonen, M. Parkkonen, J. Hartiala, K. Ylitalo, J. Pihlajamaki, K. Porkka, M. Laakso, J. Viikari, C. Ehnholm, M. R. Taskinen, and L. Peltonen. 1999. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am. J. Hum. Genet. 64: 1453-1463.
14. Pajukanta, P., I. Nuotio, J. D. Terwilliger, K. V. Porkka, K. Ylitalo, J. Pihlajamaki, A. J. Suomalainen, A. C. Syvanen, T. Lehtimaki, J. S. Viikari, M. Laakso, M. R. Taskinen, C. Ehnholm, and L. Peltonen. 1998. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat. Genet. 18: 369-373.
15. Reaven, G. M. 1993. Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu. Rev. Med. 44: 121-131.
16. Bligh, E. G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
17. Veerkamp, M. J., J. de Graaf, S. J. Bredie, J. C. Hendriks, P. N. Demacker, and A. F. Stalenhoef. 2002. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler. Thromb. Vasc. Biol. 22: 274-282.
18. Krauss, R. M., and D. M. Dreon. 1995. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am. J. Clin. Nutr. 62: 478S-487S.
19. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173.
20. Zheng, Y., K. J. Eilertsen, L. Ge, L. Zhang, J. P. Sundberg, S. M. Prouty, K. S. Stenn, and S. Parimoo. 1999. Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat. Genet. 23:268-270.
21. Castellani, L. W., A. Weinreb, J. Bodnar, A. M. Goto, M. Doolittle, M. Mehrabian, P. Demant, and A. J. Lusis. 1998. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat. Genet. 18: 374-377.
22. Bodnar, J. S., A. Chatterjee, L. W. Castellani, D. A. Ross, J. Ohmen, J. Cavalcoli, C. Wu, K. M. Dains, J. Catanese, M. Chu, S. S. Sheth, K. Charugundla, P. Dement, D. B. West, P. de Jong, and A.J. Lusis. 2002. Positional cloning of the combined hyperlipidemia gene Hyplipl. Nat. Genet. 30: 110-116.
23. Hayden, M. R., and Y. Ma. 1992. Molecular genetics of human lipoprotein lipase deficiency. Mol. Cell. Biochem. 113: 171-176.
24. Packard, C.J., J. L. H. C. Third, J. Shepherd, A. R. Lorimer, H. G. Morgan, and T. D. V. Lawrie. 1976. Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients. Metabolism. 25: 995-1006.
25. Soutar, A. K., N. B. Myant, and G. R. Thompson. 1977. Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis. 28: 247-256.
26. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89: 331-340.
27. Repa, J. J., G. Liang, J. Ou, Y. Bashmakov, J. M. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, and D. J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14: 2819-2830.
28. Ou, J., H. Tu, B. Shan, A. Luk, R. A. DeBose-Boyd, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory, element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98: 6027-6032.
29. Dixon, J. L., and H. N. Ginsberg. 1993. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: Information obtained from cultured liver cells. J. Lipid Res. 34: 167-179.
30. Boogaerts, J. R., M. Malone-McNeal, J. Archambault-Schexnayder, and R. A. Davis. 1984. Dietary carbohydrate induces lipogenesis and very-low-density lipoprotein synthesis. Am. J. Physiol 246: E77-83.
31. Shimomura, I., M. Matsuda, R. E. Hammer, Y. Bashmakov, M. S. Brown, and J. L. Goldstein. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell. 6: 77-86.
32. Parks, E. J., R. M. Krauss, M. P. Christiansen, R. A. Neese, and M. K. Hellerstein. 1999. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production and clearance. J. Clin. Invest. 104: 1087-1096.
33. Nadler, S. T., J. P. Stoehr, K. L. Schueler, G. Tanimoto, B. S. Yandell, and A. D. Attie. 2000, The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. USA. 97: 11371-11376.
34. Ducluzeau, P. H., N. Perretti, M. Laville, F. Aaldreelli, N. Vega, J. P. Riou, and H. Vidal. 2001. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes. 50: 1134-1142.
35. Diraison, F., E. Dusserre, H. Vidal, M. Sothier, and M. Beylot. 2002. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity Am. J. Physiol. Endocrinol. Metab. 282: E46-51.
36. Kolehmainen, M., H. Vidal, E. Alhava, and M. I. Uusitupa. 2001. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes. Res. 9: 706-712.
37. Shimomura, I., Y. Bashmakov, and J. D. Horton. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274: 30028-30032.
38. Nadler, S. T., and A. D. Attie. 2001. Please pass the chips: Genomic insights into obesity and diabetes. J. Nutr. 131: 2078-2081.
39. Angelin, B., K. Einarsson, K. Hellstrom, and B. Leijd. 1978. Bile acid kinetics in relation to endogenous tryglyceride metabolism in various types of hyperlipoproteinemia. J. Lipid Res. 19: 1004-1016.
40. Miyake, J. H., X. D. Doung, W. Strauss, G. L. Moore, L. W. Castellani, L. K. Curtiss, J. M. Taylor, and R. A. Davis. 2001. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase. Biol. Chem. 276: 23304-23311.
41. Witztum, J. L., G. Schonfeld, and S. W. Weidman. 1976. The effects of colestipol on the metabolism of very-low-density lipoproteins in man. J. Lab. Clin. Med. 88: 1008-1018.
42. Duane, W. C., L. A. Hartich, A. E. Bartman, and S. B. Ho. 2000. Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia. J. Lipid Res. 41: 1384-1389.
43. Wang, S. L., E. Z. Du, T. D. Martin, and R. A. Davis. 1997. Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1. J. Biol. Chem. 272: 19351-19358.
44. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlick, K. Morgan, B. Koop, S. Pimstone, J. Kastelein, M. R. Hayden, et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.